{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:56:55Z","timestamp":1787065015185,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key R&D Program of China","award":["2016YFC0905400"],"award-info":[{"award-number":["2016YFC0905400"]}]},{"name":"China National Science Foundation","award":["81871893"],"award-info":[{"award-number":["81871893"]}]},{"name":"China National Science Foundation","award":["81501996"],"award-info":[{"award-number":["81501996"]}]},{"name":"Key Project of Guangzhou Scientific Research Project","award":["201804020030"],"award-info":[{"award-number":["201804020030"]}]},{"name":"High-level university construction project of Guangzhou Medical University","award":["20182737"],"award-info":[{"award-number":["20182737"]}]},{"name":"High-level university construction project of Guangzhou Medical University","award":["201721007"],"award-info":[{"award-number":["201721007"]}]},{"name":"High-level university construction project of Guangzhou Medical University","award":["201715907"],"award-info":[{"award-number":["201715907"]}]},{"name":"High-level university construction project of Guangzhou Medical University","award":["2017160107"],"award-info":[{"award-number":["2017160107"]}]},{"name":"IVATS National key R&D Program","award":["2017YFC0907903"],"award-info":[{"award-number":["2017YFC0907903"]}]},{"name":"IVATS National key R&D Program","award":["2017YFC0112704"],"award-info":[{"award-number":["2017YFC0112704"]}]},{"name":"Application, industrialization and generalization of surgical incision protector","award":["2011B090400589"],"award-info":[{"award-number":["2011B090400589"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00432-020-03245-3","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T14:02:37Z","timestamp":1590588157000},"page":"1933-1940","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cancer risks in patients with vitiligo: a Mendelian randomization study"],"prefix":"10.1007","volume":"146","author":[{"given":"Yaokai","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caichen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengrui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1737-8192","authenticated-orcid":false,"given":"Jianxing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"issue":"11","key":"3245_CR1","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1200\/JCO.18.01223","volume":"37","author":"JM Bae","year":"2019","unstructured":"Bae JM, Chung KY, Yun SJ et al (2019) Markedly reduced risk of internal malignancies in patients with vitiligo: a nationwide population-based cohort study. J Clin Oncol 37(11):903\u2013911","journal-title":"J Clin Oncol"},{"issue":"4","key":"3245_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/bjd.16703","volume":"179","author":"L Ban","year":"2018","unstructured":"Ban L, Labbouz S, Grindlay D et al (2018) Risk of skin cancer in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol 179(4):971\u2013972","journal-title":"Br J Dermatol"},{"issue":"2","key":"3245_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1365-2133.1983.tb07077.x","volume":"109","author":"V Beral","year":"1983","unstructured":"Beral V, Evans S, Shaw H et al (1983) Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol 109(2):165\u2013172","journal-title":"Br J Dermatol"},{"issue":"5","key":"3245_CR4","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"MJ Brion","year":"2013","unstructured":"Brion MJ, Shakhbazov K, Visscher PM (2013) Calculating statistical power in Mendelian randomization studies. Int J Epidemiol 42(5):1497\u20131501","journal-title":"Int J Epidemiol"},{"issue":"7","key":"3245_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","volume":"30","author":"S Burgess","year":"2015","unstructured":"Burgess S, Scott RA, Timpson NJ et al (2015) Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol 30(7):543\u2013552","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"3245_CR6","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4049\/jimmunol.1302139","volume":"192","author":"KT Byrne","year":"2014","unstructured":"Byrne KT, Zhang P, Steinberg SM et al (2014) Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma. J Immunol 192(4):1433\u20131439","journal-title":"J Immunol"},{"issue":"9988","key":"3245_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M et al (2015) Vitiligo. Lancet 386(9988):74\u201384","journal-title":"Lancet"},{"issue":"6","key":"3245_CR8","first-page":"643","volume":"95","author":"JE Harris","year":"2015","unstructured":"Harris JE (2015) IFN-\u03b3 in vitiligo, is it the fuel or the fire? Acta Derm Venereol 95(6):643\u2013644","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"3245_CR9","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/jid.2011.463","volume":"132","author":"JE Harris","year":"2012","unstructured":"Harris JE, Harris TH, Weninger W et al (2012) A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin. J Investig Dermatol 132(7):1869\u20131876","journal-title":"J Investig Dermatol"},{"key":"3245_CR10","first-page":"191","volume":"66","author":"TJ Harrist","year":"1984","unstructured":"Harrist TJ, Pathak MA, Mosher DB et al (1984) Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo. Natl Cancer Inst Monogr 66:191\u2013196","journal-title":"Natl Cancer Inst Monogr"},{"key":"3245_CR11","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife. 7:e34408","journal-title":"Elife."},{"issue":"1","key":"3245_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1046\/j.1365-2133.2001.03952.x","volume":"144","author":"K Jimbow","year":"2001","unstructured":"Jimbow K, Chen H, Park JS et al (2001) Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 144(1):55\u201365","journal-title":"Br J Dermatol"},{"issue":"18","key":"3245_CR13","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJMoa0908547","volume":"362","author":"Y Jin","year":"2010","unstructured":"Jin Y, Birlea SA, Fain PR et al (2010) Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med 362(18):1686\u20131697","journal-title":"N Engl J Med"},{"issue":"11","key":"3245_CR14","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/ng.3680","volume":"48","author":"Y Jin","year":"2016","unstructured":"Jin Y, Andersen G, Yorgov D et al (2016) Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat Genet 48(11):1418\u20131424","journal-title":"Nat Genet"},{"issue":"14","key":"3245_CR15","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1073\/pnas.91.14.6458","volume":"91","author":"Y Kawakami","year":"1994","unstructured":"Kawakami Y, Eliyahu S, Delgado CH et al (1994) Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 91(14):6458\u20136462","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"3245_CR16","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JAC et al (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133\u20131163","journal-title":"Stat Med"},{"issue":"9","key":"3245_CR17","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.3390\/ijerph15091847","volume":"15","author":"CY Li","year":"2018","unstructured":"Li CY, Dai YX, Chen YJ et al (2018) Cancer risks in vitiligo patients: a nationwide population-based study in Taiwan. Int J Environ Res Public Health. 15(9):1847","journal-title":"Int J Environ Res Public Health."},{"issue":"5","key":"3245_CR18","doi-asserted-by":"publisher","first-page":"e37513","DOI":"10.1371\/journal.pone.0037513","volume":"7","author":"Y Lili","year":"2012","unstructured":"Lili Y, Yi W, Ji Y et al (2012) Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo. PLoS ONE 7(5):e37513","journal-title":"PLoS ONE"},{"issue":"7678","key":"3245_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","volume":"551","author":"K Michailidou","year":"2017","unstructured":"Michailidou K, Lindstr\u00f6m S, Dennis J et al (2017) Association analysis identifies 65 new breast cancer risk loci. Nature 551(7678):92\u201394","journal-title":"Nature"},{"issue":"5","key":"3245_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.diff.2009.07.007","volume":"78","author":"V Montel","year":"2009","unstructured":"Montel V, Suzuki M, Galloy C et al (2009) Expression of melanocyte-related genes in human breast cancer and its implications. Differentiation 78(5):283\u2013291","journal-title":"Differentiation"},{"issue":"6","key":"3245_CR21","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jaad.2014.07.050","volume":"71","author":"A Paradisi","year":"2014","unstructured":"Paradisi A, Tabolli S, Didona B et al (2014) Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. J Am Acad Dermatol 71(6):1110\u20131116","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3245_CR22","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/ng.3826","volume":"49","author":"CM Phelan","year":"2017","unstructured":"Phelan CM, Kuchenbaecker KB, Tyrer JP et al (2017) Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet 49(5):680\u2013691","journal-title":"Nat Genet"},{"issue":"7","key":"3245_CR23","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","volume":"178","author":"BL Pierce","year":"2013","unstructured":"Pierce BL, Burgess S (2013) Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 178(7):1177\u20131184","journal-title":"Am J Epidemiol"},{"issue":"223","key":"3245_CR24","doi-asserted-by":"publisher","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","volume":"6","author":"M Rashighi","year":"2014","unstructured":"Rashighi M, Agarwal P, Richmond JM et al (2014) CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med. 6(223):223ra23","journal-title":"Sci Transl Med."},{"issue":"3","key":"3245_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000057881","volume":"204","author":"KU Schallreuter","year":"2002","unstructured":"Schallreuter KU, Tobin DJ, Panske A (2002) Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed caucasian patients with vitiligo. Dermatology (Basel) 204(3):194\u2013201","journal-title":"Dermatology (Basel)"},{"issue":"7","key":"3245_CR26","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","volume":"50","author":"FR Schumacher","year":"2018","unstructured":"Schumacher FR, Al Olama AA, Berndt SI et al (2018) Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet 50(7):928\u2013936","journal-title":"Nat Genet"},{"issue":"04","key":"3245_CR27","first-page":"140","volume":"06","author":"KE Sharquie","year":"2016","unstructured":"Sharquie KE, Noaimi AA, Burhan ZT (2016) The frequency of skin tumors and infections in patients with autoimmune diseases. J Cosmet Dermatol Sci Appl 06(04):140\u2013147","journal-title":"J Cosmet Dermatol Sci Appl"},{"issue":"1","key":"3245_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/bjd.12111","volume":"168","author":"HE Teulings","year":"2013","unstructured":"Teulings HE, Overkamp M, Ceylan E et al (2013) Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. Br J Dermatol 168(1):162\u2013171","journal-title":"Br J Dermatol"},{"issue":"9","key":"3245_CR29","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/jid.2009.32","volume":"129","author":"JG van den Boorn","year":"2009","unstructured":"van den Boorn JG, Konijnenberg D, Dellemijn TAM et al (2009) Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Investig Dermatol 129(9):2220\u20132232","journal-title":"J Investig Dermatol"},{"issue":"6","key":"3245_CR30","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/jid.2011.16","volume":"131","author":"JG van den Boorn","year":"2011","unstructured":"van den Boorn JG, Picavet DI, van Swieten PF et al (2011) Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. J Investig Dermatol 131(6):1240\u20131251","journal-title":"J Investig Dermatol"},{"issue":"3","key":"3245_CR31","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EDE.0000000000000081","volume":"25","author":"TJ VanderWeele","year":"2014","unstructured":"VanderWeele TJ, Tchetgen Tchetgen EJ, Cornelis M et al (2014) Methodological challenges in mendelian randomization. Epidemiology 25(3):427\u2013435","journal-title":"Epidemiology"},{"issue":"7","key":"3245_CR32","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/ng.3002","volume":"46","author":"Y Wang","year":"2014","unstructured":"Wang Y, McKay JD, Rafnar T et al (2014) Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet 46(7):736\u2013741","journal-title":"Nat Genet"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03245-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T19:44:33Z","timestamp":1622058273000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03245-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,27]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["3245"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03245-3","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,27]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"There are no patients involved in our study design, recruitment or research conduction, and thus, there is no need for ethical approval. No patient was asked to make recommendations about the interpretation or writing of the results. There are no plans to disseminate the results of the study to study participants or relevant patient communities. Thus, there is no need for informed consent in our study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}